Lacosamide
CAS No. 175481-36-4
Lacosamide( Erlosamide | SPM 927 | ADD 234037 )
Catalog No. M12653 CAS No. 175481-36-4
An anticonvulsant compound that enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLacosamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn anticonvulsant compound that enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels.
-
DescriptionAn anticonvulsant compound that enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels; launched for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain.Epilepsy Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsErlosamide | SPM 927 | ADD 234037
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaNeurological Disease
-
IndicationEpilepsy
Chemical Information
-
CAS Number175481-36-4
-
Formula Weight250.294
-
Molecular FormulaC13H18N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NCC1=CC=CC=C1)[C@H](NC(C)=O)COC
-
Chemical Name(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hao JX, et al. Eur J Pharmacol. 2006 Dec 28;553(1-3):135-40.
2. Lees G, et al. Neuropharmacology. 2006 Jan;50(1):98-110.
3. Duncan GE, et al. Epilepsy Res. 2005 Oct-Nov;67(1-2):81-7.
molnova catalog
related products
-
AZD-1305
AZD-1305 is a novel antiarrhythmic agent that predominantly blocks the rapid component of Ikr.
-
VX-150
VX-150 is a highly selective NaV1.8 inhibitor relative to the other sodium channel subtypes (>400-fold).
-
AZD 7009
AZD 7009 is a novel antiarrhythmic agent that inhibits the late sodium current in CHO K1 cells expressing hNav1.5 with IC50 of 11 uM.